Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

IRDye800CW-labeled GPC3-targeted agent

A fluorescence imaging agent and an immunoconjugate comprised of a glypican 3 (GPC3)-targeting moiety conjugated to the near-infrared (NIR) fluorescent dye IRDye800CW, that can potentially be used for the imaging of GPC3-expressing tumor cells. Upon administration of the IRDye800CW-labeled GPC3-targeted agent, the GPC3-targeting moiety targets and binds to GPC3 expressed on tumor cells. Upon fluorescence imaging of the fluorophore IRDye800CW, the GPC3-expressing tumor cells can be visualized and detected. GPC3, a heparan sulfate proteoglycan and a member of the glypican family, is overexpressed on certain tumor cell types while minimally expressed on normal, healthy cells; GPC3 plays an important role in cellular proliferation and differentiation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-glypican-3-IRDye800CW
anti-GPC3-IRDye800CW
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search